title: Functional recruitment of human complement inhibitor C4B-binding protein to outer membrane protein Rck of Salmonella.
abstract: Resistance to complement mediated killing, or serum resistance, is a common trait of pathogenic bacteria. Rck is a 17 kDa outer membrane protein encoded on the virulence plasmid of Salmonella enterica serovars Typhimurium and Enteritidis. When expressed in either E. coli or S. enterica Typhimurium, Rck confers LPS-independent serum resistance as well as the ability to bind to and invade mammalian cells. Having recently shown that Rck binds the inhibitor of the alternative pathway of complement, factor H (fH), we hypothesized that Rck can also bind the inhibitor of the classical and lectin pathways, C4b-binding protein (C4BP). Using flow cytometry and direct binding assays, we demonstrate that E. coli expressing Rck binds C4BP from heat-inactivated serum and by using the purified protein. No binding was detected in the absence of Rck expression. C4BP bound to Rck is functional, as we observed factor I-mediated cleavage of C4b in cofactor assays. In competition assays, binding of radiolabeled C4BP to Rck was reduced by increasing concentrations of unlabeled protein. No effect was observed by increasing heparin or salt concentrations, suggesting mainly non-ionic interactions. Reduced binding of C4BP mutants lacking complement control protein domains (CCPs) 7 or 8 was observed compared to wt C4BP, suggesting that these CCPs are involved in Rck binding. While these findings are restricted to Rck expression in E. coli, these data suggest that C4BP binding may be an additional mechanism of Rck-mediated complement resistance.
authors.affiliation: Infection Biology Program, Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland.
authors.forename: Derek K
authors.initials: DK
authors.lastname: Ho
authors.forename: Jorma
authors.initials: J
authors.lastname: Tissari
authors.forename: Hanna M
authors.initials: HM
authors.lastname: Järvinen
authors.forename: Anna M
authors.initials: AM
authors.lastname: Blom
authors.forename: Seppo
authors.initials: S
authors.lastname: Meri
authors.forename: Hanna
authors.initials: H
authors.lastname: Jarva
mesh_terms: D000328:Adult; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology / Q000378:metabolism*; D003167:Complement Activation / Q000187:drug effects; D015935:Complement C4b / Q000037:antagonists & inhibitors* / Q000378:metabolism; D050716:Complement C4b-Binding Protein / Q000276:immunology / Q000378:metabolism*; D003169:Complement Inactivator Proteins / Q000276:immunology / Q000378:metabolism*; D004926:Escherichia coli / Q000276:immunology / Q000378:metabolism; D005434:Flow Cytometry; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D011485:Protein Binding; D012475:Salmonella / Q000276:immunology*; D012480:Salmonella Infections / Q000276:immunology* / Q000378:metabolism; D012965:Sodium Chloride / Q000494:pharmacology; D014774:Virulence / Q000187:drug effects
chemical_list: D001425:Bacterial Outer Membrane Proteins; D050716:Complement C4b-Binding Protein; D003169:Complement Inactivator Proteins; D012965:Sodium Chloride; D015935:Complement C4b; D006493:Heparin
references.citation: Mol Immunol. 2010 Mar;47(6):1299-305
references.pmid: 20022381
references.citation: Structure. 1999 Oct 15;7(10):1301-9
references.pmid: 10545325
references.citation: Cell Res. 2010 Jun;20(6):647-64
references.pmid: 20368731
references.citation: J Immunol. 2007 May 15;178(10):6359-66
references.pmid: 17475865
references.citation: Infect Immun. 1994 Nov;62(11):5183-6
references.pmid: 7927803
references.citation: J Biol Chem. 2001 Jul 20;276(29):27136-44
references.pmid: 11369776
references.citation: N Engl J Med. 2001 Apr 5;344(14):1058-66
references.pmid: 11287977
references.citation: Nat Rev Microbiol. 2008 Feb;6(2):132-42
references.pmid: 18197169
references.citation: J Immunol. 2002 Dec 1;169(11):6352-60
references.pmid: 12444142
references.citation: J Immunol. 2009 Jun 15;182(12):7865-77
references.pmid: 19494311
references.citation: Mol Immunol. 2004 Apr;40(18):1333-46
references.pmid: 15072852
references.citation: J Immunol. 2010 Aug 1;185(3):1763-9
references.pmid: 20622116
references.citation: J Immunol Methods. 2005 Feb;297(1-2):83-95
references.pmid: 15777933
references.citation: Mol Immunol. 2009 Sep;46(14):2808-17
references.pmid: 19477524
references.citation: Infect Immun. 1996 Jun;64(6):2019-23
references.pmid: 8675302
references.citation: J Exp Med. 1982 Mar 1;155(3):797-808
references.pmid: 6801179
references.citation: J Immunol. 2005 May 15;174(10):6299-307
references.pmid: 15879129
references.citation: Biochem Soc Trans. 2002 Nov;30(Pt 6):978-82
references.pmid: 12440957
references.citation: Microbiology (Reading). 2005 Mar;151(Pt 3):863-873
references.pmid: 15758232
references.citation: PLoS Pathog. 2008 Aug 29;4(8):e1000140
references.pmid: 18769718
references.citation: J Immunol. 1996 Dec 1;157(11):4935-9
references.pmid: 8943398
references.citation: J Immunol. 1992 Feb 1;148(3):827-36
references.pmid: 1730875
references.citation: J Bacteriol. 1992 Jan;174(1):84-91
references.pmid: 1729227
references.citation: J Exp Med. 2001 Feb 5;193(3):281-95
references.pmid: 11157049
references.citation: FEBS Lett. 2007 May 1;581(9):1716-20
references.pmid: 17418141
references.citation: J Clin Invest. 1992 Sep;90(3):953-64
references.pmid: 1522243
references.citation: J Med Microbiol. 2008 Aug;57(Pt 8):938-946
references.pmid: 18628492
references.citation: J Immunol. 2000 May 15;164(10):5328-36
references.pmid: 10799895
references.citation: Infect Immun. 2008 Sep;76(9):4100-9
references.pmid: 18625735